Please login to the form below

Not currently logged in
Email:
Password:

Patheon hires Covance's Michael Lehmann for global pharma role

He joins the contract development and manufacturing company as president of global pharmaceutical development services

Michael Lehmann has left contract research organisation Covance to join Patheon as president of global pharmaceutical development services.

Patheon, which provides both contract development and manufacturing services to pharma companies, said that Lehmann's appointment will help drive the company's growth as it continues to transform its business amid varying marketing conditions.

This includes the company's recent acquisition of speciality pharma firm Banner Pharmacaps for $255m.

"I am pleased to be welcoming Mike and getting him quickly integrated with Patheon's leadership team," stated James Mullen, Patheon's CEO.

"He is a highly accomplished senior executive with a proven track record in the healthcare, life sciences and drug development sectors.”

Lehmann's most recent role was corporate senior VP and general manager of the global early development business of the contract research organisation (CRO) Covance.

During his time in this role, he helped Covance secure deals with both Lilly and Sanofi.

Prior to joining Covance, Lehmann spent 17 years at GE Healthcare in several senior roles, including general manager of multivendor services.

2nd November 2012

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics